Loading…
West Pharmaceutical Services, Inc. is projected to rise to $442.80 by 2027, a +25% move from its current price of $353.71. WST is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $349.50 | $353.96 | $358.48 | +0.07% |
| Jul 14 | $347.92 | $354.21 | $360.63 | +0.14% |
| Jul 15 | $346.77 | $354.47 | $362.34 | +0.21% |
| Jul 16 | $345.84 | $354.72 | $363.83 | +0.29% |
| Jul 17 | $345.05 | $354.97 | $365.18 | +0.36% |
| Jul 18 | $344.36 | $355.23 | $366.44 | +0.43% |
| Jul 19 | $343.75 | $355.48 | $367.61 | +0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $343.75 | $355.48 | $367.61 | +0.50% |
| Week 2 | $340.70 | $357.26 | $374.62 | +1.00% |
| Week 3 | $338.77 | $359.04 | $380.53 | +1.51% |
| Week 4 | $337.42 | $360.84 | $385.89 | +2.02% |
| Week 5 | $336.43 | $362.65 | $390.90 | +2.53% |
| Week 6 | $335.70 | $364.46 | $395.68 | +3.04% |
| Week 7 | $335.17 | $366.28 | $400.29 | +3.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies.
The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors.
West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
West Pharmaceutical Services, Inc. (WST) is currently trading at $354.68, with a market cap of $24.79B and a rank of 5531. The price outlook is summarized by a long-run forecast that shows a path from a 2026 average price of $354.68 to progressively higher averages in later years, ending with the 2050 forecast average at $5,509.27.
The forecast indicates a broad bullish trajectory after 2026, with multi-year upside potential and sizable planned growth in average prices through 2030, 2040, and 2050.
A major floor 34.7% below — a decisive break under it would weaken the trend.
The nearest floor, 11.7% below — buyers have tended to step in here.
The nearest ceiling, 3.4% above — a clean break opens room to run.
A major ceiling 12.4% above — clearing it would confirm fresh momentum.
Key WST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of WST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $355.75 | Sell | $355.76 | Sell |
| MA 10 | $357.40 | Sell | $353.75 | Sell |
| MA 20 | $344.94 | Buy | $346.21 | Buy |
| MA 50 | $325.69 | Buy | $325.85 | Buy |
| MA 100 | $290.27 | Buy | $304.40 | Buy |
| MA 200 | $278.49 | Buy | $286.13 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.97 | Neutral |
| Stoch RSI (14) | 7.20 | Buy |
| CCI (20) | 46.31 | Neutral |
| Williams %R (14) | -33.39 | Info |
| MACD (12,26,9) | -0.49 | Sell |
| ROC (12) | 5.15 | Buy |
| Bollinger %B (20,2) | 0.66 | Neutral |
| Stochastic %K (14) | 66.61 | Neutral |
| TRIX (15) | 0.48 | Buy |
| Awesome (5,34) | 21.44 | Buy |
| Ultimate (7,14,28) | 52.60 | Neutral |
| Momentum (10) | 7.15 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 353.74 | Sell |
| ADX (14) | 33.60 | Buy |
| ATR (14) | 4.08 | Info |
The near-term technical picture is bullish, with the RSI at 70 indicating strong momentum. The stock sits above the SMA50 of $314.55 and above the SMA200 of $274.41, which supports a constructive trend. Current support is at $302.89 and resistance at $354.68, framing a 30-day range of $323.36 to $389.04.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $230.95 | $353.71 | $466.51 | 0% | Neutral | |
| $362.67 | $442.80 | $565.25 | +25% | Bullish | |
| $424.51 | $528.06 | $692.31 | +49% | Bullish | |
| $566.77 | $715.89 | $958.57 | +102% | Bullish | |
| $635.68 | $813.79 | $1,109.27 | +130% | Bullish | |
| $694.61 | $900.09 | $1,246.31 | +154% | Bullish | |
| $809.12 | $1,060.32 | $1,489.06 | +200% | Bullish | |
| $835.78 | $1,106.79 | $1,574.45 | +213% | Bullish | |
| $935.18 | $1,250.73 | $1,800.47 | +254% | Bullish | |
| $1,161.08 | $1,567.56 | $2,281.69 | +343% | Bullish | |
| $1,697.87 | $2,390.83 | $3,646.88 | +576% | Bullish | |
| $3,559.20 | $5,375.19 | $8,788.84 | +14.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $230.95 | $353.71 | $422.14 | +0.00% |
| August 2026 | $316.50 | $370.46 | $443.00 | +4.74% |
| September 2026 | $320.94 | $377.47 | $454.91 | +1.89% |
| October 2026 | $314.96 | $371.96 | $451.23 | -1.46% |
| November 2026 | $314.25 | $372.42 | $454.28 | +0.12% |
| December 2026 | $320.04 | $380.50 | $466.51 | +2.17% |
Click any year to see its month-by-month WST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
West Pharmaceutical Services, Inc.'s 2026 outlook centres on $353.71, within a $230.95 to $466.51 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, WST could reach as high as $565.25, with a base case around $442.80 and support toward $362.67 — roughly +25% from $353.71. Momentum favours further upside here.
Expect WST to range from $424.51 to $692.31 through 2028. The $528.06 average target implies a +49% move from current prices. That is up +19% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The WST price prediction for 2029 points to an average of $715.89 (low $566.77, high $958.57) — a potential gain of +102% on today's $353.71. Momentum favours further upside here.
In 2030, WST is projected to trade between $635.68 and $1,109.27, averaging $813.79 — a potential gain of +130% from today's $353.71. That is up +14% on the projected 2029 average. Buyers look set to stay in control over this stretch.
West Pharmaceutical Services, Inc.'s 2031 outlook centres on $900.09, within a $694.61 to $1,246.31 range. That is up +11% on the projected 2030 average. That marks a +154% change versus current levels. Momentum favours further upside here.
By 2032, WST could reach as high as $1,489.06, with a base case around $1,060.32 and support toward $809.12 — roughly +200% from $353.71. Buyers look set to stay in control over this stretch.
Expect WST to range from $835.78 to $1,574.45 through 2033. The $1,106.79 average target implies a +213% move from current prices. That is up +4% on the projected 2032 average. Momentum favours further upside here.
The WST price prediction for 2034 points to an average of $1,250.73 (low $935.18, high $1,800.47) — a potential gain of +254% on today's $353.71. Buyers look set to stay in control over this stretch.
In 2035, WST is projected to trade between $1,161.08 and $2,281.69, averaging $1,567.56 — a potential gain of +343% from today's $353.71. That is up +25% on the projected 2034 average. Momentum favours further upside here.
West Pharmaceutical Services, Inc.'s 2040 outlook centres on $2,390.83, within a $1,697.87 to $3,646.88 range. That is up +53% on the projected 2035 average. That marks a +576% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, WST could reach as high as $8,788.84, with a base case around $5,375.19 and support toward $3,559.20 — roughly +14.2x from $353.71. Momentum favours further upside here.
Investing $1,000 in WST today (≈ 2.827175 WST) could be worth
$15,196.59
+$14,196.59 (+1420%) by 2050 · US Dollar
Based on the average projected WST price of $5,375.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in WSTwould be worth at today's price.
$1,000 invested in WST on Jul 10, 2025 (≈ 4.362431 WST) would be worth
$1,543.04
+$543.04 (+54.3%) today · 1.54× · US Dollar
Based on a WST entry price of $229.23 vs. today's $353.71.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $365.74 | $967.11 | -3.3% |
| 1 month ago | $330.92 | $1,068.87 | +6.9% |
| 3 months ago | $256.55 | $1,378.72 | +37.9% |
| 6 months ago | $272.91 | $1,296.07 | +29.6% |
| 1 year ago | $229.23 | $1,543.04 | +54.3% |
| All time (5.0y) ago | $372.65 | $949.17 | -5.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our WST forecast.
Our base-case forecast reaches $710.00 around 2029.
Implied market cap at $710.00: $50.16B
The multi-year forecast shows sustained upside with a bullish sentiment across the horizon. In 2027 the average price is $446.48 with a range of $365.42 to $570.52 and an ROI of 25.9%. By 2028 the average rises to $542.69 (min $436.04, max $712.04; ROI 53) and by 2029 to $727.96 (min $576.05, max $975.33; ROI 105.2).
The 2030 forecast places the average at $822.49 (min $642.21, max $1,121.75; ROI 131.9) and 2031 at $924.33 (min $713.05, max $1,280.49; ROI 160.6). Looking further, 2032 shows an average of $1,084.26 (min $827.10, max $1,523.35; ROI 205.7) and 2033 at $1,119.99 (min $845.47, max $1,593.87; ROI 215.8). The trajectory continues with 2034 at $1,288.74 (min $963.29, max $1,855.88; ROI 263.4) and 2035 at $1,619.23 (min $1,198.99, max $2,357.71; ROI 356.5).
The forecast then extends to 2040 with an average of $2,489.93 (min $1,767.79, max $3,799.06; ROI 602) and finally to 2050 with an average of $5,509.27 (min $3,647.22, max $9,009.83; ROI 1453.3). All years are bullish in sentiment.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $822.49 with a range of $642.21 to $1,121.75, and a bullish sentiment. The ROI is projected at 131.9%.
The forecast shows bullish sentiment for 2027 and beyond, with increasing average prices and positive ROIs (e.g., 25.9% in 2027, 53% in 2028, 105.2% in 2029, rising to 131.9% in 2030 and 1453.3% by 2050). The 2026 year is neutral with an average price of $354.68 and ROI of 0.
Yes. The forecast indicates that multiple years surpass $1,000, including 2032 with an average of $1,084.26 and a max of $1,523.35, and 2033 with a max of $1,593.87; by 2034 the max is $1,855.88.
The near-term picture shows bullish sentiment with RSI at 70. The stock is above the SMA50 ($314.55) and SMA200 ($274.41), with a 30-day range of $323.36 to $389.04 and a current price of $354.68.
The 2050 forecast shows an average price of $5,509.27 with a min of $3,647.22 and a max of $9,009.83, and a bullish sentiment with an ROI of 1453.3.
West Pharmaceutical Services, Inc. Community Discussion
0Share your West Pharmaceutical Services, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.